Answers are grounded in this paper and cite their sources.
Candida albicans is known to be one of the major causative agents of opportunistic infection.It is well known that patients with candidiasis often possess underlying diseases and immunodeficient or -suppressive conditions (4,10,(12)(13)(14)(15)(16).Recently antifungal agents have been widely used for the treatment of this fungal infection.However, antifungal chemotherapy alone often fails to eradicate the microorganisms and most antifungal chemotherapeutics are not feasible for long-term administration because of their toxicity.In a search for immunopotentiative agents against candida infection, OK-432 (a streptococcal preparation, Picibanil) which had been developed as an anticancer agent by Okamoto et al ( 17) was found to protect animals from the infection.Detailed studies on OK-432 have already revealed that this agent stimulates host defense mechanisms in terms of activation of macrophages (9,22,23), activation of complement (11,22), T-lymphocyte activation ( 22), granulopoiesis (6), and other mechanisms (18), in addition to having anticancer effects (1, 7, 9).However, there is no report on the therapeutic effect of OK-432 against fungal infection.This paper describes the effect of OK-432 treatment on the stimulation of host defense mechanisms against candida infection.Candida albicans 7N, which was isolated from a patient with pulmonary candidiasis and maintained in our culture collection, was used throughout these experiments.Candida cells were collected from 18-hr cultures on Sabouraud's dextrose agar, centrifuged and washed three times with saline to give a cell suspension for the inoculum.Male BALB/c mice, 4 weeks old and weighing 14-17 g, were used.Each experimental group consisted of 10 mice.OK-432 (Picibanil) was furnished by Chugai Pharm.Co.One KE of agent corresponds to 0.1 mg dry weight of bacterial cells.This agent was administered intraperitoneally to each mouse in a daily dose of 0.5 KE for 4 days.Control mice were injected with saline.Two days after the discontinuation of the treatment, the mice were inoculated intravenously with 5 x 104 cells of C. albicans.For the enumeration of the viable fungal units in organs, mice were sacrificed 3 days after the candida challenge, and the liver, kidney, and spleen were removed, weighed and placed separately in tissue homogenizers.Sterile saline was added to give a final volume of 10 ml.Each organ was homogenized and dilutions were made with saline.The number of viable fungal cells in the homogenate was determined by the plate dilution method on Sabouraud's dextrose agar containing 0.002%
No takes yet. Share an insight, caveat, or question.
Shiraishi et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: